MENU
Aim higher

BiSECT

Development of a potent bispecific antibody combination to treat colon cancer with reduced toxicity

Start date: 
15-02-2015
Project Duration: 
29months
Technological Area: 
In vitro Testing, Trials
Market Area: 
Other therapeutic (including defibrillators)